Leadership Team
Executive Team
Business Teams
Latest Maxim Group News
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on
March 24, 2023
Intchains Group Limited Announces Pricing of US$8.0 Million Initial Public Offering
Intchains Group Limited (the “Company” or “Intchains Group”), a provider of integrated solutions consisting of
March 16, 2023
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company
March 16, 2023